Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Megan Noe, M.D.

Title
Institution
Department
Address
Profile Picture

Biography
Kalamazoo College, Kalamazoo, MIBA6/2004Biology
Tufts University School of Medicine, Boston, MAMD, MPH5/2011Medicine
University of Iowa Hospitals and Clinics, Iowa City, IA6/2015Dermatology Residency
University of Pennsylvania, Philadelphia, PAMSCE5/2019Clinical Epidemiology
2007 - 2009
Doris Duke Research Fellow
2017
NIH Loan Repayment Award

Overview
I am a dermatologist and epidemiologist focused on the care of adults with chronic skin diseases. My clinical research program focuses on using clinical epidemiology and pharmacoepidemiology to guide the care of patients with chronic skin diseases, with a focus on the adverse effects of dermatologic therapies, encompassing both the infectious complications of immunosuppressive therapies and severe cutaneous drug reaction like Stevens-Johnson syndrome/toxic epidermal necrolysis.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23AR073932 (NOE, MEGAN H) Jul 1, 2019 - Jun 30, 2023
    NIH/NIAMS
    Respiratory infections and vaccination behaviors in patients with chronic inflammatory skin diseases
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Wang LL, Noe MH, Micheletti RG. Long-term sequelae from Stevens-Johnson syndrome / toxic epidermal necrolysis in a large retrospective cohort. J Am Acad Dermatol. 2020 Apr 11. PMID: 32289398.
    Citations:    
  2. Noe MH, Shin DB, Wehner MR, Margolis DJ, Gelfand JM. Opioid Prescribing in Adults with and without Psoriasis. J Am Acad Dermatol. 2020 Apr 01. PMID: 32246971.
    Citations:    
  3. Sharma P, Bryer JS, Price S, Noe MH, Rosenbach M. A prospective comparison of cutaneous sarcoidosis disease response to immunomodulatory and immunosuppressive therapies. J Am Acad Dermatol. 2020 Jun; 82(6):1546-1548. PMID: 32151628.
    Citations:    
  4. Nelson CA, Zhong CS, Hashemi DA, Ashchyan HJ, Brown-Joel Z, Noe MH, Imadojemu S, Micheletti RG, Vleugels RA, Wanat KA, Rosenbach M, Mostaghimi A. A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria. JAMA Dermatol. 2020 Mar 01; 156(3):270-279. PMID: 31940000.
    Citations:    
  5. Noe MH, Gelfand JM, Bryer JS, Price SN, Judson MA, Rosenbach M. Responsiveness to Change and Establishment of the Minimal Clinically Important Difference for the Cutaneous Sarcoidosis Activity and Morphology Instrument. JAMA Dermatol. 2020 Jan 01; 156(1):98-99. PMID: 31721981.
    Citations:    
  6. Wehner MR, Micheletti R, Noe MH, Linos E, Margolis DJ, Naik HB. Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions. J Am Acad Dermatol. 2020 May; 82(5):1239-1241. PMID: 31866261.
    Citations:    
  7. Rosenthal J, Smith RJ, Noe MH. Ulcerated tophaceous gout. Eur J Rheumatol. 2020 Jul; 7(3):146-147. PMID: 31782718.
    Citations:    
  8. Hannah CE, Keller JR, Noe MH, Gordon JRS, Fridlington EK, Ceilley RI, Liu V. Phacomatosis pigmentokeratotica without extracutaneous abnormalities: 12-year follow-up. JAAD Case Rep. 2019 Dec; 5(12):1055-1057. PMID: 31788526.
    Citations:    
  9. Noe MH, Shin DB, Doshi JA, Margolis DJ, Gelfand JM. Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database J Drugs Dermatol. 2019 Aug 01; 18(8):745-750. PMID: 31424706.
    Citations:    
  10. Noe MH, Hubbard RA, Micheletti RG. The ABCD-10 Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-Reply. JAMA Dermatol. 2019 Jul 31. PMID: 31365027.
    Citations:    
  11. Gelfand JM, Shin DB, Alavi A, Torigian DA, Werner T, Papadopoulos M, Takeshita J, Noe MH, Dey AK, Playford MP, Mehta NN. A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial). J Invest Dermatol. 2020 01; 140(1):85-93.e2. PMID: 31326395.
    Citations:    
  12. Noe MH, Wan MT, Shin DB, Armstrong AW, Duffin KC, Chiesa Fuxench ZC, Kalb RE, Menter A, Simpson EL, Takeshita J, Tyring SK, Van Voorhees AS, Mehta NN, Gelfand JM. Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. J Am Acad Dermatol. 2019 Oct; 81(4):923-930. PMID: 31163241.
    Citations:    
  13. Noe MH, Micheletti RG, Mostaghimi A. Timing of mucocutaneous symptoms and medication discontinuation in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol. 2019 12; 81(6):1410-1412. PMID: 31085266.
    Citations:    
  14. Margolis DJ, Shin D, Noe MH, Wan MT, Bhate K, Wang S, Hoffstad O, Takeshita J, Gelfand JM. Lack of association of biologic therapy for psoriasis with psychiatric illness: An electronic medical records cohort study. J Am Acad Dermatol. 2019 Sep; 81(3):709-716. PMID: 31054973.
    Citations:    
  15. Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10. JAMA Dermatol. 2019 04 01; 155(4):448-454. PMID: 30840032.
    Citations:    
  16. Hashemi DA, Brown-Joel ZO, Tkachenko E, Nelson CA, Noe MH, Imadojemu S, Vleugels RA, Mostaghimi A, Wanat KA, Rosenbach M. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes. JAMA Dermatol. 2019 04 01; 155(4):455-459. PMID: 30785603.
    Citations:    
  17. Chitgopeker P, Sidey K, Aronson A, Hammel J, Noe MH, Auh S, Lehrer M, Hopp S, Johnson-Jahangir H, VanBeek M, Ferguson N. Factors Associated With Patient-Initiated Communication After Mohs Micrographic Surgery. Dermatol Surg. 2019 02; 45(2):234-243. PMID: 30640776.
    Citations:    
  18. Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, Papadopoulos M, Shin DB, Takeshita J, Werner TJ, Mehta NN, Gelfand JM. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials. J Am Acad Dermatol. 2019 Jun; 80(6):1630-1639. PMID: 30654078.
    Citations:    
  19. Ogdie A, Kay McGill N, Shin DB, Takeshita J, Jon Love T, Noe MH, Chiesa Fuxench ZC, Choi HK, Mehta NN, Gelfand JM. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. Eur Heart J. 2018 10 14; 39(39):3608-3614. PMID: 28444172.
    Citations: 3     Fields:    
  20. Noe MH, Shin DB, Hubbard RA, Hennessy S, Gelfand JM. Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases. J Invest Dermatol. 2019 02; 139(2):473-475. PMID: 30315780.
    Citations:    
  21. Madu PN, Williams VL, Noe MH, Omech BG, Kovarik CL, Wanat KA. Autoimmune skin disease among dermatology outpatients in Botswana: a retrospective review. Int J Dermatol. 2019 Jan; 58(1):50-53. PMID: 30168847.
    Citations:    
  22. Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. J Invest Dermatol. 2018 11; 138(11):2315-2321. PMID: 29758282.
    Citations:    Fields:    
  23. Noe MH, Mostaghimi A. The Challenges of Big Data in Dermatology. J Am Acad Dermatol. 2018 May 09. PMID: 29753065.
    Citations:    Fields:    
  24. Noe MH, Rosenbach M. Inpatient Dermatologists-Crucial for the Management of Skin Diseases in Hospitalized Patients. JAMA Dermatol. 2018 05 01; 154(5):524-525. PMID: 29453867.
    Citations:    
  25. Ashchyan HJ, Butler DC, Nelson CA, Noe MH, Tsiaras WG, Lockwood SJ, James WD, Micheletti RG, Rosenbach M, Mostaghimi A. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum. JAMA Dermatol. 2018 04 01; 154(4):409-413. PMID: 29450453.
    Citations: 2     Fields:    
  26. Noe MH, Mostaghimi A, Rosenbach M, Shinkai K, Micheletti RG. Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors. J Invest Dermatol. 2018 09; 138(9):2068-2072. PMID: 29559345.
    Citations:    Fields:    
  27. Noe MH, Gelfand JM. Research Techniques Made Simple: Pharmacoepidemiology Research Methods in Dermatology. J Invest Dermatol. 2018 02; 138(2):e13-e18. PMID: 29389330.
    Citations:    
  28. Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM. Psoriasis and the risk of diabetes: A prospective population-based cohort study. J Am Acad Dermatol. 2018 02; 78(2):315-322.e1. PMID: 29128465.
    Citations:    
  29. Rodriguez O, Noe MH, Sehgal C, Schultz S, Rosenbach M. Quantification of granuloma volume and response to treatment in cutaneous sarcoidosis using 3-dimensional high-frequency ultrasound scan. JAAD Case Rep. 2017 Nov; 3(6):522-523. PMID: 29264382.
    Citations:    
  30. Ogdie A, Grewal SK, Noe MH, Shin DB, Takeshita J, Chiesa Fuxench ZC, Carr RM, Gelfand JM. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study. J Invest Dermatol. 2018 04; 138(4):760-767. PMID: 29104161.
    Citations:    
  31. Nelson CA, Noe MH, McMahon CM, Gowda A, Wu B, Ashchyan HJ, Perl AE, James WD, Micheletti RG, Rosenbach M. Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center. J Am Acad Dermatol. 2018 02; 78(2):303-309.e4. PMID: 29107342.
    Citations:    Fields:    Translation:Humans
  32. Noe MH, Rosenbach M. Cutaneous sarcoidosis. Curr Opin Pulm Med. 2017 09; 23(5):482-486. PMID: 28598873.
    Citations:    
  33. Noe MH, Rodriguez O, Taylor L, Sultan L, Sehgal C, Schultz S, Gelfand JM, Judson MA, Rosenbach M. High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2017; 34(2):136-141. PMID: 29628755.
    Citations:    
  34. Noe MH, Shin DB, Wan MT, Gelfand JM. Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study. J Invest Dermatol. 2018 01; 138(1):228-230. PMID: 28843488.
    Citations:    
  35. Noe MH, Grewal SK, Shin DB, Ogdie A, Takeshita J, Gelfand JM. Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population-based study in the United Kingdom. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1674-1680. PMID: 28485831.
    Citations:    
  36. Fenton PH, Landherr MJ, Noe MH, Ciliberto H, Wanat KA. Healthy infant with a blistering rash. J Fam Pract. 2017 03; 66(3):E1-E3. PMID: 28258979.
    Citations:    
  37. Dore E, Noe MH, Swick BL. Trichoblastoma, syringocystadenoma papilliferum, desmoplastic trichilemmoma and tumor of the follicular infundibulum with signet-ring cells, all arising in nevus sebaceus. J Cutan Pathol. 2015 Sep; 42(9):645-51. PMID: 25761672.
    Citations:    
  38. Noe MH, Drake A, Link BK, Liu V. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal. J Cutan Pathol. 2013 Aug; 40(8):714-9. PMID: 23651057.
    Citations:    
  39. Noe MH, Messingham KA, Brandt DS, Andrews JI, Fairley JA. Pregnant women have increased incidence of IgE autoantibodies reactive with the skin and placental antigen BP180 (type XVII collagen). J Reprod Immunol. 2010 Jun; 85(2):198-204. PMID: 20471095.
    Citations:    
  40. Messingham KA, Noe MH, Chapman MA, Giudice GJ, Fairley JA. A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid. J Immunol Methods. 2009 Jul 31; 346(1-2):18-25. PMID: 19422829.
    Citations:    
  41. Noe MH, Chen M, Woodley DT, Fairley JA. Familial epidermolysis bullosa acquisita. Dermatol Online J. 2008 Dec 15; 14(12):2. PMID: 19265615.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Noe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (176)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.